However, the treatment of angiogenesis-induced proliferative diabetic retinopathy has been investigated by numerous researchers, whereby several novel procedures have instructed such as using anti-vascular endothelial growth factor (VEGF) agents, non-steroidal anti-inflammatory (NSAID) drugs, or laser therapy [11, 12]. The gene discussed is VEGFA; the disease is proliferative diabetic retinopathy.